Short Summary
The PTAB held that Apple’s wearable physiological measurement claims were obvious over prior‑art pulse‑oximetry references, rendering all challenged claims unpatentable. The decision relied on Lisogurski, Carlson, and Mannheimer teachings.
Detailed Summary
In IPR2019‑00916 concerning U.S. Patent No. 9,651,533 B2, the Patent Trial and Appeal Board affirmed the institution of the review and subsequently found claims 5, 7‑10, 13, and 15‑17 unpatentable under 35 U.S.C. §103(a). The Board concluded that the combination of Lisogurski’s wearable physiological monitoring system, Carlson’s LED pulsing techniques for improving signal‑to‑noise ratio, and Mannheimer’s spaced detector configuration rendered the asserted claim limitations obvious to a person of ordinary skill in the art. All challenged claims were therefore cancelled, leaving the patent unenforceable.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsWilus Institute of Standards and Technology Inc.
Wilus requested permission to address recent PTAB director‑review decisions and submit new evidence for five IPRs against Samsung. The Director denied the request, leaving the IPRs proceeding without the proposed extensions or additional evidence.
Amazon.com, Inc. et al.vsNokia Technologies Oy
Amazon and Nokia settled their dispute over U.S. Patent 11,805,267 B2, leading the PTAB to terminate the inter partes review after the parties jointly requested termination and sought confidentiality for the settlement documents.
Inter IKEA Systems B.V.vsPOINTWISE VENTURES, LLC
Inter IKEA Systems petitions the PTAB to invalidate claims 1‑12 of Pointwise Ventures’ ’812 patent, arguing anticipation by Darrell and obviousness over Boncyk, Darrell, and Fukuda.
Meta Platforms, Inc.vsSitNet, LLC
Meta Platforms petitions the PTAB to invalidate SitNet’s ’290 patent, asserting that all fourteen claims are obvious over six prior‑art references previously used in IPR2024‑00530.
Meta Platforms, Inc.vsMullen Industries LLC
Meta Platforms successfully petitioned to institute IPR against Mullen Industries LLC regarding augmented reality and location-based gaming claims. The Board found a reasonable likelihood of obviousness over Levesque and Ronzani, setting the stage for trial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.